Jane Street’s Innovator IBD ETF Leaders ETF LDRS Stock Holding History

Jane Street’s Portfolio LDRS Stock Details LDRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-11,358	Closed	-$211K	–	7754
2020 Q1	$211K	Sell	11,358 -6,106	-35%	-$131K	﹤0.01%	4595
2019 Q4	$393K	Buy	+17,464	New	+$387K	﹤0.01%	3973
2019 Q3	–	Sell	-20,151	Closed	-$427K	–	6035
2019 Q2	$427K	Buy	+20,151	New	+$426K	﹤0.01%	3782
2019 Q1	–	Sell	-33,547	Closed	-$717K	–	5905
2018 Q4	$717K	Buy	33,547 +4,360	+15%	+$99.6K	﹤0.01%	3015
2018 Q3	$741K	Buy	29,187 +14,044	+93%	+$357K	﹤0.01%	3135
2018 Q2	$382K	Buy	15,143 +870	+6%	+$21.5K	﹤0.01%	3881
2018 Q1	$351K	Buy	+14,273	New	+$367K	﹤0.01%	3854

Other funds holding LDRS

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street's LDRS Position: Q2 2020 in Review

Jane Street sold out of Innovator IBD ETF Leaders ETF (LDRS) in Q2 2020, closing a stake of 11,358 shares — an estimated $211K sold.

Jane Street first reported a position in LDRS in Q1 2018 and held it in 7 quarters. The position peaked at $741K in Q3 2018. 4 funds tracked by Wall St. Rank hold LDRS as of Q2 2020.

Jane Street reported no remaining Innovator IBD ETF Leaders ETF position as of Q2 2020 after selling out during the quarter.
Jane Street sold 11,358 Innovator IBD ETF Leaders ETF shares in Q2 2020, an estimated $211K.
Jane Street first reported a position in Innovator IBD ETF Leaders ETF in Q1 2018 and held it in 7 quarters.
Jane Street's Innovator IBD ETF Leaders ETF position peaked at $741K in Q3 2018.
4 funds tracked by Wall St. Rank held Innovator IBD ETF Leaders ETF as of Q2 2020.

Based on Jane Street's 13F filing for Q2 2020, filed 17 Aug 2020.